214 related articles for article (PubMed ID: 38051969)
1. The Role of the Gut Microbiome in Cancer: A Review, With Special Focus on Colorectal Neoplasia and Clostridioides difficile.
Anderson SM; Sears CL
Clin Infect Dis; 2023 Dec; 77(Suppl 6):S471-S478. PubMed ID: 38051969
[TBL] [Abstract][Full Text] [Related]
2. The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity.
Lesniak NA; Schubert AM; Flynn KJ; Leslie JL; Sinani H; Bergin IL; Young VB; Schloss PD
mBio; 2022 Aug; 13(4):e0118322. PubMed ID: 35856563
[TBL] [Abstract][Full Text] [Related]
3. Domestic canines do not display evidence of gut microbial dysbiosis in the presence of Clostridioides (Clostridium) difficile, despite cellular susceptibility to its toxins.
Stone NE; Nunnally AE; Jimenez V; Cope EK; Sahl JW; Sheridan K; Hornstra HM; Vinocur J; Settles EW; Headley KC; Williamson CHD; Rideout JR; Bolyen E; Caporaso JG; Terriquez J; Monroy FP; Busch JD; Keim P; Wagner DM
Anaerobe; 2019 Aug; 58():53-72. PubMed ID: 30946985
[TBL] [Abstract][Full Text] [Related]
4. Gut associated metabolites and their roles in
Aguirre AM; Sorg JA
Gut Microbes; 2022; 14(1):2094672. PubMed ID: 35793402
[TBL] [Abstract][Full Text] [Related]
5. Interactions Between the Gastrointestinal Microbiome and Clostridium difficile.
Theriot CM; Young VB
Annu Rev Microbiol; 2015; 69():445-61. PubMed ID: 26488281
[TBL] [Abstract][Full Text] [Related]
6. 2'-Fucosyllactose inhibits proliferation of
Wiese M; Schuren FHJ; Smits WK; Kuijper EJ; Ouwens A; Heerikhuisen M; Vigsnaes L; van den Broek TJ; de Boer P; Montijn RC; van der Vossen JMBM
Front Cell Infect Microbiol; 2022; 12():991150. PubMed ID: 36389156
[TBL] [Abstract][Full Text] [Related]
7.
Cheng JKJ; Unnikrishnan M
Microbiology (Reading); 2023 Feb; 169(2):. PubMed ID: 36848200
[No Abstract] [Full Text] [Related]
8. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD
mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161
[TBL] [Abstract][Full Text] [Related]
9. Dietary Xanthan Gum Alters Antibiotic Efficacy against the Murine Gut Microbiota and Attenuates
Schnizlein MK; Vendrov KC; Edwards SJ; Martens EC; Young VB
mSphere; 2020 Jan; 5(1):. PubMed ID: 31915217
[TBL] [Abstract][Full Text] [Related]
10. The development of live biotherapeutics against
Zhang Y; Saint Fleur A; Feng H
Gut Microbes; 2022; 14(1):2052698. PubMed ID: 35319337
[No Abstract] [Full Text] [Related]
11. The Initial Gut Microbiota and Response to Antibiotic Perturbation Influence Clostridioides difficile Clearance in Mice.
Tomkovich S; Stough JMA; Bishop L; Schloss PD
mSphere; 2020 Oct; 5(5):. PubMed ID: 33087520
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota in burned patients with Clostridioides difficile infection.
Shoaei P; Shojaei H; Siadat SD; Moshiri A; Vakili B; Yadegari S; Ataei B; Khorvash F
Burns; 2022 Aug; 48(5):1120-1129. PubMed ID: 34924229
[TBL] [Abstract][Full Text] [Related]
13. Clostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota.
Fletcher JR; Pike CM; Parsons RJ; Rivera AJ; Foley MH; McLaren MR; Montgomery SA; Theriot CM
Nat Commun; 2021 Jan; 12(1):462. PubMed ID: 33469019
[TBL] [Abstract][Full Text] [Related]
14. Clostridioides difficile carriage in animals and the associated changes in the host fecal microbiota.
Thanissery R; McLaren MR; Rivera A; Reed AD; Betrapally NS; Burdette T; Winston JA; Jacob M; Callahan BJ; Theriot CM
Anaerobe; 2020 Dec; 66():102279. PubMed ID: 33022384
[TBL] [Abstract][Full Text] [Related]
15. Negative interactions determine Clostridioides difficile growth in synthetic human gut communities.
Hromada S; Qian Y; Jacobson TB; Clark RL; Watson L; Safdar N; Amador-Noguez D; Venturelli OS
Mol Syst Biol; 2021 Oct; 17(10):e10355. PubMed ID: 34693621
[TBL] [Abstract][Full Text] [Related]
16. Integrating gut microbiome and host immune markers to understand the pathogenesis of
Ke S; Pollock NR; Wang XW; Chen X; Daugherty K; Lin Q; Xu H; Garey KW; Gonzales-Luna AJ; Kelly CP; Liu YY
Gut Microbes; 2021; 13(1):1-18. PubMed ID: 34132169
[No Abstract] [Full Text] [Related]
17. Microbe-microbe interactions during Clostridioides difficile infection.
Abbas A; Zackular JP
Curr Opin Microbiol; 2020 Feb; 53():19-25. PubMed ID: 32088581
[TBL] [Abstract][Full Text] [Related]
18. Dissecting Individual Interactions between Pathogenic and Commensal Bacteria within a Multispecies Gut Microbial Community.
Hassall J; Cheng JKJ; Unnikrishnan M
mSphere; 2021 Mar; 6(2):. PubMed ID: 33762315
[TBL] [Abstract][Full Text] [Related]
19. Metabolic adaption to extracellular pyruvate triggers biofilm formation in Clostridioides difficile.
Tremblay YDN; Durand BAR; Hamiot A; Martin-Verstraete I; Oberkampf M; Monot M; Dupuy B
ISME J; 2021 Dec; 15(12):3623-3635. PubMed ID: 34155333
[TBL] [Abstract][Full Text] [Related]
20. Impact of environmental conditions and gut microbiota on the in vitro germination and growth of Clostridioides difficile.
Martinez E; Rodriguez C; Crèvecoeur S; Lebrun S; Delcenserie V; Taminiau B; Daube G
FEMS Microbiol Lett; 2022 Oct; 369(1):. PubMed ID: 36066913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
